MaaT Pharma Announces 2022 Annual Results and Provides a Business Overview
LYON, France , March 30 /Businesswire/ - With the construction of our manufacturing facility and the roadmap we shared at the beginning of the year, we are excited with the progress we have made to advance our microbiome therapies that we believe could become a new pillar in treating cancer.